Sonia Hallen
Investment Manager at Gilde Healthcare
Amsterdam, North Holland
Overview
Work Experience
Investment Manager
2024 - Current
Focused on Gilde’s private therapeutics strategy in the Venture & Growth team. Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. Sonia is dedicated to the Venture&Growth fund of Gilde Healthcare, which invests in fast growing companies active in therapeutics, medtech and digital health, based in Europe and North America.
Founder and Board Member
2018
A unique medicines company that uses Artificial Intelligence to tailor therapies for unique patients.
Vice President
2022 - 2024
Board Member
2021 - 2024
Board Observer
2021 - 2024
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Raised $268,000,000.00 from NEXTBio Capital, RTW Investments, Longwood Fund, RA Capital Management, Sectoral Asset Management, Marshall Wace, Avego Bioscience Capital, SymBiosis, FemHealth Ventures and Andera Partners.
Board Observer
2022 - 2023
Associate
2019 - 2022
One of Europe's largest and most experienced Life Sciences investment firms. Venture Capitalist focused on unlisted companies developing innovative therapeutics, medical devices, diagnostics and digital health platforms.
LSP BioVentures is a venture capital fund focused on opportunities in the life science arena.
Consultant - Life Sciences
2016 - 2018
Helped companies rethink, reshape or restructure businesses to deliver better patient outcomes and drive shareholder returns.
Stem Cell Therapies Scientist
2012 - 2016
Developed biomaterial-based regenerative therapies for treatment of cardiac diseases.
Founder & CEO
2014 - 2015
Early stage start-up developing smart point-of-care solutions to treat and diagnose infectious diseases.